NCT04013646 is a Phase 1, PHASE2 clinical trial of Umbilical cord blood infusion in Stroke, sponsored by Bundang CHA Hospital.

Who is sponsoring NCT04013646?

NCT04013646 is sponsored by Bundang CHA Hospital.

What drugs are being tested in NCT04013646?

Interventions in NCT04013646: Umbilical cord blood infusion, Erythropoietin injection, Placebo umbilical cord blood infusion, Placebo erythropoietin injection, Active rehabilitation.

What condition does NCT04013646 study?

NCT04013646 studies Stroke, Umbilical Cord Blood, Erythropoietin, Safety, Treatment Outcome.

Is NCT04013646 still recruiting?

NCT04013646 is currently status unknown. Last updated 5 November 2020.

Last reviewed 2020-11-05 · How we verify

NCT04013646

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Combination Therapy of Umbilical Cord Blood and Erythropoietin for Stroke Paients

Status unknown Phase 1, PHASE2 Last updated 5 November 2020

What this trial tests

Phase 1, PHASE2 trial testing Umbilical cord blood infusion in Stroke in 24 participants. Status unknown.

Timeline

2 May 2019

Primary endpoint
2 November 2020

2 November 2021

Quick facts

Lead sponsor	Bundang CHA Hospital
Phase	Phase 1, PHASE2
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	24
Start date	2 May 2019
Primary completion	2 November 2020
Estimated completion	2 November 2021
Sites	1 location across South Korea

Drugs / interventions tested

Umbilical cord blood infusion — full drug profile →
Erythropoietin injection
Placebo umbilical cord blood infusion
Placebo erythropoietin injection
Active rehabilitation

Conditions studied

Stroke — all drugs for Stroke →
Umbilical Cord Blood — all drugs for Umbilical Cord Blood →
Erythropoietin — all drugs for Erythropoietin →
Safety — all drugs for Safety →

Sponsor

Bundang CHA Hospital

Who can join

20 and older, any sex, with Stroke or Umbilical Cord Blood. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This clinical trial is a clinical trial for the evaluation of the safety and efficacy of umbilical cord blood (UCB) therapy, UCB and erythropoietin (EPO) combination therapy in adult stroke patients.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Mechanism of inflammatory response and therapeutic effects of stem cells in ischemic stroke: current evidence and future perspectives.
Wang Y, Yuan T, Lyu T, Zhang L, et al · · 2025 · cited 16× · PMID 38767477 · DOI 10.4103/1673-5374.393104
Safety and efficacy of allogeneic umbilical cord blood cells and erythropoietin combination therapy in patients with subacute stroke.
Kim JM, Shin S, Lee D, Choi JI, et al · · 2025 · PMID 41456040 · DOI 10.1186/s13287-025-04856-8

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke · recruiting
NCT07494890 — Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment · NA · recruiting
NCT07356011 — Exoskeleton for Balance · NA · recruiting
NCT07523503 — Unilateral Versus Bilateral Task-specific Training on Motor Impairment, Upper Extremity Function, and Hand Dexterity in · NA · recruiting
NCT06704074 — Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients · NA · recruiting

Other Bundang CHA Hospital trials

Trials by the same sponsor.

NCT07366554 — Epigenetic Factors of Colorectal Adenoma in Korean · not yet recruiting
NCT06982573 — The Effect of Magnetic Stimulation on Low Back Pain Relief and Muscle Mass Maintenance in Patients With ESRD · NA · recruiting
NCT06982586 — A Prospective, Single-Center, Single-Arm, Investigator-Initiated Exploratory Clinical Trial to Assess the Safety of Repe · NA · not yet recruiting
NCT06995274 — Umbilical Cord Blood Therapy in a Child With Eosinophilic Duodenitis and Autism Spectrum Disorder: a Case Study · NA · not yet recruiting
NCT06543797 — A Pilot Clinical Trial Study to Determine the Safety of the Application of a Wearable Medical Electromagnetic Generator · EARLY_PHASE1 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04013646 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Bundang CHA Hospital
Last refreshed: 5 November 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04013646.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing